Pfizer heads into 2026 with a share price still shaped by the boom and bust of COVID products and a shareholder base that ...

Pfizer (PFE) spent up to $7.3 billion buying a biotech company most people have never heard of — and it may be its greatest move in years. Metsera, the firm Pfizer acquired, is modest yet ambitious.

Pfizer Inc. (NYSE:PFE) shares closed slightly higher on Wednesday. The New York-based pharmaceutical giant recently said that the European Commission approved PREVNAR 20, a caccine to help protect ...

NEW YORK (Reuters) - A study of Pfizer Inc's Sutent was halted early after the medicine delayed progression of a rare form of pancreatic cancer affecting tens of thousands of people globally, ...

Pfizer is playing catch-up in the crowded field of obesity medicines, but it hoped to compete with a daily pill alternative to currently available injectable GLP-1 products. Instead, Pfizer is ...

ABUJA, June 20 (Reuters) - Pfizer Inc and Nigeria are keen to reach an out-of-court settlement over a 1996 drug trial that Nigeria says caused the death of 11 children and left dozens disabled, a ...